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background: Endometriosis has a strong genetic component, and numerous genetic studies have been reported.
methods: We have systematically reviewed these studies and included 114 in our ﬁnal selection.
results: We found no consistent evidence linking endometriosis with speciﬁc polymorphisms in genes encoding inﬂammatory mediators,
proteins involved in sex steroid metabolism, vascular function and tissue remodelling. Although a number of polymorphisms have been
associated with endometriosis in selected populations, the associations have not been independently conﬁrmed, either because only
single studies were carried out on these markers/genes or because other studies reported no association. The most solid evidence
linking speciﬁc polymorphisms to endometriosis came from studies investigating glutathione-S-transferase, a phase II detoxiﬁcation
enzyme. Carriage of the GSTT1 null deletion variant showed consistent association with endometriosis with a 29% increased risk;
however, it cannot be excluded that this result was due to publication bias, and this association should be independently conﬁrmed in
large-scale, well-designed case–control studies.
conclusions: The evidence of an association between genetic polymorphisms and endometriosis is weak. Carriage of the GSTT1 null
deletion may moderately increase the risk of this disease. We suggest that the methodology of association studies should be improved in
order to identify and validate associations in endometriosis.
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Introduction
The association between genetic polymorphisms and clinical disease has
long been recognized. For example, a relationship between blood group
and gastrointestinal cancer was described in the 1950s (Billington, 1956).
More recently, technological advances in molecular biology have fuelled
theinterestinmolecularpolymorphismsandtheirinﬂuenceonthesuscep-
tibility and clinical presentation of diseases (Tempfer et al., 2004).
Many aspects of female reproductive function are strongly inﬂu-
enced by genetic factors, and numerous studies have attempted to
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Advanced Access publication on September 19, 2008 doi:10.1093/humupd/dmn040identify susceptibility genes for disorders affecting female fertility such
as polycystic ovary syndrome, endometriosis, ﬁbroids, cancer (ovarian,
vulvar, cervical), premature ovarian failure, recurrent pregnancy loss
and pre-eclampsia (Levanat et al., 2004; Modugno, 2004; Escobar-
Morreale et al., 2005; Goswami and Conway, 2005; Tempfer et al.,
2005; Ferreira et al., 2006; Layman, 2006). For many of these con-
ditions, the search for genetic disease markers is ongoing, and no
strong candidate has yet emerged.
Endometriosis is characterized by the presence and growth of
endometrial cells outside the uterus, which impair fertility (Wenzl
et al., 2003; Halis and Arici, 2004), and the disease has a strong
genetic component (Treloar et al., 1999; Bischoff and Simpson,
2004; Vigano et al., 2007). In a study of the genetic inﬂuence on endo-
metriosis risk in an Australian twin sample, for example, the risk ratio
of affected versus population prevalence was 3.58 for monozygotic
twins and 2.32 for dizygotic twins (Treloar et al., 1999). Clarifying
the genetic etiology of endometriosis would have implications for diag-
nosis, identiﬁcation of individuals at risk and the development of tar-
geted therapeutics.
This disorder has been the focus of a large number of association
studies investigating a wide variety of polymorphisms. Previous
reviews assessed the possible role of speciﬁc polymorphisms or
groups of polymorphisms, indicating that the number of robust associ-
ations may be low (Falconer et al., 2007). Some have even challenged
the evidence for endometriosis having a genetic background (Di and
Guo, 2007).
In this review, we assess evidence for the role of genetic poly-
morphisms in endometriosis. We present a systematic review of the
published literature across all polymorphisms investigated in relation
to endometriosis. We have evaluated the reliability and strength of
the evidence for each of the 114 selected studies and discuss
methods for improving association studies. However, to enable
proper evalauation of the studies, we ﬁrst explore the methodology
of molecular association.
Genetic association studies
of polymorphisms
The genetic basis of disease may be elucidated in different ways. One
approach is to scan across the genome to identify markers/genes of
interest; a second approach is to investigate speciﬁc ‘candidate’
genes. We discuss these approaches below, and provide examples
of such studies in endometriosis.
Genome-wide linkage analysis using affected sibling-pairs has been
applied to endometriosis by Australian, British and Icelandic groups
(Stefansson et al., 1998; Treloar et al., 2000; Kennedy et al., 2001).
These studies aim to ﬁnd chromosomal regions shared by related indi-
viduals harbouring disease-predisposing genes. In these linkage studies,
which are conceptually different from case–control studies in unre-
lated individuals, a possible informative locus on chromosome 10q
has been reported (Treloar et al., 2000). In addition, in a separate
linkage analysis of families with three or more affected members,
Zondervan et al. (2007) suggested that there may be one or more
high-penetrance susceptibility loci for endometriosis on chromosome
7. A dominant mode of inheritance with reduced penetrance and a
recessive mode of inheritance with high penetrance have been
suggested for these potential genetic variants. To our knowledge,
genome-wide genetic association studies on unrelated individuals
have not been carried out.
Genetic case–control studies identify markers/genes that are
associated with a trait of interest, such as a given disease. Genetic
association studies do not, however, prove an etiological link
between the polymorphism and/or the gene in question and the
investigated trait. Once identiﬁed, the association of a speciﬁc
genetic marker within a candidate gene with the trait should be inves-
tigated further. Speciﬁcally, it has to be clariﬁed, whether the allele of
interest has a direct biological effect or whether the association is
based on biological effects downstream of the allele, which are in
linkage disequilibrium. Since linkage disequilibrium may vary in different
populations, this is an important source of inconsistency.
A particular problem in interpreting the results from genetic associ-
ation studies in endometriosis is linked to the fact that this is not a
monogenic trait but a complex trait. Therefore, various genetic
factors can be expected to have an effect with an additional level of
variation regarding the individual effect sizes. Especially small effect
sizes may be easily missed in individual studies with small sample
sizes. Common methodological problems in genetic association
studies include low sample size, chance ﬁndings, multiple comparisons
and subsequent type I error inﬂation, different ethnic backgrounds of
the study subjects, varying disease deﬁnitions and inclusion/exclusion
criteria and ascertainment bias. To help overcome these methodologi-
cal problems, Zondervan et al. (2002) proposed the following criteria
for case–control studies to identify an association between genetic
polymorphisms and endometriosis: (i) use newly diagnosed, i.e. inci-
dent, cases with endometriosis, (ii) collect information predating
symptoms and (iii) use at least one population-based female control
group matched for unadjustable confounders and ideally also screened
for pelvic symptoms. These criteria for high-quality case–control
studies, however, have not been fulﬁlled by the majority of the
studies discussed in this review. Therefore, positive associations
between genetic polymorphisms and endometriosis have to be inter-
preted with caution.
Ethnic background is an important source of variation. As illustrated
by this review, genetic associations are often inconsistent across ethnic
barriers, which may be due to different frequencies of polymorphic
alleles as well as gene–gene interactions. In this respect, a genetic
association, although valid in a speciﬁc ethnic population, may not
be relevant for individuals of another ethnicity. This has to be acknowl-
edged when judging the external validity of any genetic association
study.
Some of these methodological problems can be overcome—at
least in part—by summarizing data from individual studies in the
form of a meta-analysis. This tool has been increasingly used to
conﬁrm or rule out associations. Applying meta-analysis can be gen-
erally expected to conﬁrm only a fraction of associations previously
reported in individual small studies. Also, a strong association in indi-
vidual studies with a P-value ,0.001 has been reported to be a
good predictor of conﬁrmation in a meta-analysis (Lohmueller
et al., 2003).
In this review, we have assessed the quality of evidence for every
group of polymorphisms investigated in endometriosis association
studies according to the agreement between studies, the presence
or absence of meta-analyses and the strength of the association.
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WesystematicallysearchedthePubMedandEMBASEdatabasesforgene
associationstudiespublisheduptotheendofAugust2007usingtheterm
‘endometriosis’ combined with ‘polymorphism OR polymorphisms’ or
‘mutationORmutations’.Thesearchwasnotlimitedbylanguageofpub-
lication. Translations of non-English papers were not obtained. The prin-
cipleauthor(C.B.T.) selected relevantstudiesusing thefollowingcriteria:
all studies investigating polymorphic genetic variants with cases, i.e.
womenwithaclinicaland/orsurgicaldiagnosisofendometriosisirrespec-
tive of disease stage, and with controls, i.e. women irrespective of deﬁ-
nition of controls, listing absolute numbers of the respective genotype
distributions. The interpretation of the consistency of an association
with endometriosis always refers to a speciﬁc polymorphism and not to
any investigated polymorphism in a speciﬁc gene.
Results
The search for endometriosis susceptibility polymorphisms was
focused mainly on genes involved in inﬂammation, sex steroid regu-
lation, metabolism, biosynthesis, detoxiﬁcation, vascular function and
tissue remodelling.
Genes of inﬂammatory mediators
It is widely accepted that endometriosis is an inﬂammatory process,
associated with altered immune cell function, immune cell numbers,
and elevated levels of inﬂammatory cytokines (Agic et al., 2006).
This observation has led researchers to investigate the effects of poly-
morphisms in genes encoding cytokines and other molecules involved
in inﬂammation (see Table I).
Cytokines
In Taiwanese women, the 2509C/T promoter polymorphism in the
transforming growth factor (TGF) b1 gene (Hsieh et al., 2005f), the
881T/C polymorphism in the interleukin (IL)-2 receptor b gene
(Hsieh et al., 2005b) and the 2627A/C promoter polymorphism in
the IL-10 gene (Hsieh et al., 2003) have all been associated to endo-
metriosis susceptibility. Two polymorphisms in the promoter region of
the IL-10 gene, 21082G/A and 2592C/A [note that this is the same
as the 2627A/C single-nucleotide polymorphism (SNP) studied by
Hsieh et al. (2003)], have been investigated in Japanese women but
do not appear to inﬂuence endometriosis susceptibility in this popu-
lation (Kitawaki et al., 2002). However, the same research group
found that the genotype for the CA repeat microsatellite in the
interferon-g gene may have an effect on endometriosis susceptibility
in Japanese women (Kitawaki et al., 2004). Polymorphisms in genes
encoding other interleukins (IL-1b, IL-4, IL-6 and IL-18) and their
receptors (IL-1 receptor and IL-12 receptor b) have been investigated
but failed to show a consistent association with endometriosis suscep-
tibility (Hsieh et al., 2001a, 2002, 2005b; Lee et al., 2002; Wieser
et al., 2003a, b; Bhanoori et al., 2005b; Kitawaki et al., 2006; Wen
et al., 2006). Wieser et al. (2003a) suggest that the IL-6 promoter
polymorphism 174G/C predisposes women to endometriosis with
chocolate cysts. In one study, carriage of the IL-1 receptor antagonist
A2 allele was associated with endometriosis in a Chinese population
(Wen et al., 2006). D’Amora et al. (2006) also reported that the
BsrBI C/A, but not the PstI C/T polymorphism of the IL-1 receptor
gene, is associated with a reduced risk of endometriosis.
The insulin-like growth factor II (IGF2) ApaI polymorphism was not
found to be associated with endometriosis in Taiwanese women
(Hsieh et al., 2004c). Also, a polymorphism in the TGF beta 1 gene
(509C/T) was not associated with deep inﬁltrating endometriosis in
Dutch women (van Kaam et al., 2007a).
A number of groups have investigated a possible link between poly-
morphisms in the tumour necrosis factor (TNF) gene and increased
endometriosis risk. Polymorphisms in the promoter region of the
TNF-a gene do not appear to inﬂuence endometriosis risk in
Korean, Taiwanese or Caucasian women (Hsieh et al., 2002; Lee
et al., 2002; Wieser et al., 2002a). An Australian study investigating
26 polymorphisms in the promoter and coding regions of TNF also
found no association with endometriosis (Zhao et al., 2007).
However, the 21031T/C TNF promoter polymorphism may affect
disease severity in Japanese women (Asghar et al., 2004). In Japanese
women, the TNF-U01 haplotype (21031T, 2863C, 2857C) has
also been linked to endometriosis susceptibility, although it should
be noted that this haplotype is in strong linkage disequilibrium with
the HLA-B*0702 allele, making it difﬁcult to determine which gene is
responsible for the association (Teramoto et al., 2004). A Chinese
study found an association between endometriosis and the þ252
polymorphism in intron 1 of the TNF beta gene (Luo et al., 2006).
Nitric oxide and adhesion molecules
Elevated levels of the pro-inﬂammatory molecule nitric oxide (NO)
have been reported in women with endometriosis (Wu et al.,
2003). Endothelial NO synthase catalyses the production of NO,
and the p.E298D polymorphism in the NOS3 gene has been associated
with endometriosis susceptibility (Zervou et al., 2003). Intercellular
adhesion molecule-1 (ICAM-1) is thought to mediate interactions
between endometrial cells and lymphocytes during the pathogenesis
of endometriosis (Vigano et al., 2003). In Caucasian women, the
p.G241R polymorphism in the ICAM1 gene may inﬂuence disease
severity (Vigano et al., 2003), but neither this nor the p.K469E poly-
morphism appear to have a direct inﬂuence on endometriosis suscep-
tibility in either Caucasian or Japanese women (Vigano et al., 2003;
Yamashita et al., 2005; Kitawaki et al., 2006). The PmII C/T poly-
morphism of the epithelial cadherin (CDH1) gene was associated
with late-stage endometriosis in Taiwanese women (Hsieh et al.,
2005c). In a Chinese study, the CDH1 30-UTR C/T polymorphism,
but not the 2160C/A or 2347G/GA promoter polymorphisms,
was associated with endometriosis (Shan et al., 2007).
Human leukocyte antigens
Human leukocyte antigens (HLAs) are key components of the major
histocompatibility complex (MHC), which is involved in immune cell
signalling processes such as T-cell activation. HLA genes involved in
both MHC I (HLA-A and HLA-B) and MHC II (HLA-DPB1, HLA-DQB1
and HLA-DRB1) have been studied in women with endometriosis. A
study of Chinese women found that HLA-B genotype, but not HLA-A
genotype, inﬂuences endometriosis susceptibility (Wang et al.,
2001). In Japanese women, both the HLA-DRB1*1403 and
HLA-DQB1*0301 alleles have been linked to increased endometriosis
risk, whereas HLA-DPB1 alleles do not appear to affect susceptibility
(Ishii et al., 2002, 2003). It should be noted that the HLA-DRB1 and
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Table I Polymorphisms of genes encoding inﬂammatory mediators, which have been investigated for their role in endometriosis
Gene (locus, protein name
and its function)
Variant Association with susceptibility Phenotype
Name dbSNP ID Positive (number of cases,
number of controls)
Negative (number of
cases, number of
controls)
CCL5 [17q11.2-q12, chemokine
(C–C motif) ligand 5 (RANTES):
chemokine]
2403G/A rs2107538 Spanish women (63, 36 or
110) (Antinolo et al., 2003)
228C/G rs2280788 Spanish women (63, 36 or
110) (Antinolo et al., 2003)
CCR2 (3p21.31, monocyte
chemotactic protein 1 receptor:
chemokine receptor)
p.V64I rs1799864 Spanish women (63, 36 or
110) (Antinolo et al., 2004)
CCR5 (3p21.31, chemokine
(C–C motif) receptor 5:
chemokine receptor)
Delta32 (32 bp deletion) rs333 Spanish women (63, 36 or
110) (Antinolo et al., 2004)
CDH1 (16q22.1, epithelial
cadherin 1: adhesion molecule)
PmlI RFLP (30-UTR C/T) rs1801026 Taiwanese women (150, 159)
(Hsieh et al., 2005c)
Chinese women (152, 189)
(Shan et al., 2007)
2160C/A rs1620 Chinese women: 2160A
2347GA haplotype. (152, 189)
(Shan et al., 2007)
2347G/GA rs5030625 Chinese women: 2160A
2347GA haplotype. (152, 189)
(Shan et al., 2007)
CDKN1A (6p21.2,
cyclin-dependent kinase inhibitor
1A (p21): regulation of cell cycle)
p.S31R rs1801270 Taiwanese women (102,
119) (Hsieh et al., 2001c)
CTLA4 (2q33, cytotoxic T
lymphocyte antigen-4: T-cell
ligand)
49A/G rs231775 Italian women (143, 165)
(Vigano et al., 2005)
CT60A/G rs3087243 Italian women (146, 153)
(Vigano et al., 2005)
EGFR (7p12, epidermal growth
factor receptor: regulates cell
growth and differentiation)
2073A/T rs17337023 Taiwanese women (122, 139)
(Hsieh et al., 2005e)
FAS (10q24.1, FAS: mediates
apoptosis)
21377G/A rs2234767 Spanish women (78, 57 or
108) (Fernandez et al., 2005)
2670A/G rs1800682 Spanish women (78, 57 or
108) (Fernandez et al., 2005)
FASLG (1q23, FAS ligand:
mediates apoptosis)
2844C/T rs763110 Spanish women (78, 57 or
108) (Fernandez et al., 2005)
1
0
0
T
e
m
p
f
e
r
e
t
a
l
.HLA-A (6p21.3, human leukocyte
antigen-A: major
histocompatibility I protein)
HLA-A Chinese women (40, 50)
(Wang et al., 2001)
HLA-B (6p21.3, human leukocyte
antigen-B: major
histocompatibility I protein)
HLA-B Chinese women: HLA-B46,
HLA-B48 alleles (40, 50) (Wang
et al., 2001)
HLA-DPB1 (6p21.3, human
leukocyte antigen DP b1: major
histocompatibility II protein)
HLA-DPB1*01-*03, *0401-*0402, *05, *06,
*08-*11, *13-*19
Japanese women (83, 222)
(Ishii et al., 2003)
HLA-DQB1 (6p21.3, human
leukocyte antigen DQ b1: major
histocompatibility II protein)
HLA-DQB1*0201, *0301-*0303, *0401-*0402,
*0501-*0503, *0601-*0604
Japanese women:
HLA-DQB1*0301 allele (83, 222
or 117) (Ishii et al., 2003)
HLA-DRB1 (6p21.3, human
leukocyte antigen DR b1: major
histocompatibility II protein)
HLA-DRB1*0101, *0301, *0401-*0408, *0410,
*0701, *0801-*0803, *09, *10, *1101, *1104,
*1201-*1202, *1301-*1302, *1401, *1402,
*1404, *1405, *1501, *1502, *1602 (þ *0102,
*0103, *0302, *0804, *1602, *1305 in Japanese
study) (þ *1111, *1339, *1406, *1407, *1412 in
Korean study)
Japanese women:
HLA-DRB1*1403 (83, 222) (Ishii
et al., 2002)
Chinese women (only
looking at HLA-DRB1*1501
& *1502) (40, 50) (Wang
et al., 2002)
Korean women (100, 800 or
108) (Whang et al., 2006)
ICAM1 (19p13.3-p13.2,
intercellular adhesion
molecule-1: adhesion molecule)
p.G241R rs1799968 Caucasian women (180, 175)
(Vigano et al., 2003)
Japanese women (126, 172)
(Yamashita et al., 2005)
Caucasian women;
disease severity
(Vigano et al.,
2003)
p.K469E rs5498 Japanese women. Association
only seen in combination with
IL-6 -634G (202, 236) (Kitawaki
et al., 2006)
Caucasian women (180,
175) (Vigano et al., 2003)
Japanese women (126, 172)
(Yamashita et al., 2005)
IFNG (12q14, interferon-g:
cytokine)
CA repeat Japanese women (185, 176)
(Kitawaki et al., 2004)
IGF2 (11p15.5, insulin-like
growth factor II: cytokine)
ApaI RFLP (17 200G/A) rs680 Taiwanese women (120,
103) (Hsieh et al., 2004c)
IL4 (5q31.1, interleukin-4:
cytokine)
2590C/T rs2243250 Taiwanese women (120,
106) (Hsieh et al., 2002)
Japanese women (185, 176)
(Kitawaki et al., 2004)
70 bp VNTR (intron 3) Taiwanese women (120,
106) (Hsieh et al., 2002)
IL6 (7p21, interleukin-6:
cytokine)
2174G/C rs1800795 Korean women (70, 202)
(Lee et al., 2002)
Austrian women (94, 70)
(Wieser et al., 2003a)
South Indian women (232,
210) (Bhanoori et al., 2005b)
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Table I Continued
Gene (locus, protein name
and its function)
Variant Association with susceptibility Phenotype
Name dbSNP ID Positive (number of cases,
number of controls)
Negative (number of
cases, number of
controls)
2634C/G (2572C/G) rs1800796 Japanese women. Association
only seen in combination with
ICAM1 p.469E/E genotype (202,
236) (Kitawaki et al., 2006)
IL10 (1q31-q32, interleukin-10:
cytokine)
21082G/A rs1800896 Japanese women (196, 160)
(Kitawaki et al., 2002)
2627A/C
(2592C/A)
rs1800872 Taiwanese women (130, 133)
(Hsieh et al., 2003)
Japanese women (196, 160)
(Kitawaki et al., 2002)
IL18 (11q22.2-q22.3,
interleukin-18: cytokine)
105A/C rs549908 Taiwanese women (150,
159) (Hsieh et al., 2005b)
IL1B (2q14, interleukin-1b:
cytokine)
2511C/T rs16 944 Taiwanese women (120,
103) (Hsieh et al., 2001a)
Chinese women (138, 100)
(Wen et al., 2006)
3953C/T rs1143634 Austrian women (92, 69)
(Wieser et al., 2003b)
Taiwanese women (120,
103) (Hsieh et al., 2001a)
Chinese women (138, 100)
(Wen et al., 2006)
IL1R1 (2q11.2, interleukin-1
receptor 1: cytokine receptor)
PstI RFLP rs2041748 Brazilian women (109, 114)
(D’Amora et al., 2006)
BsrBI RFLP No dbSNP ID Brazilian women (109, 114)
(D’Amora et al., 2006)
IL2RB (22q13.1, interleukin-2
receptor b: cytokine receptor)
881T/C rs228953 Taiwanese women (150, 159)
(Hsieh et al., 2005b)
IL1RN (2q14.2, interleukin-1R
antagonist: cytokine)
86 bp VNTR (intron 2) Chinese women (138, 100)
(Wen et al., 2006)
Taiwanese women (120,
103) (Hsieh et al., 2001a)
IL12RB1 (19p13.1, interleukin-12
receptor b: cytokine receptor)
p.G378R rs401502 Taiwanese women (150,
159) (Hsieh et al., 2005b)
NOS3 (7q36, endothelial nitric
oxide synthase: catalyses
synthesis of nitric oxide, a
pro-inﬂammatory molecule)
p.E298D rs1799983 Caucasian women in Greek
population (94, 60) (Zervou
et al., 2003)
TGFB1 (19q13.1, transforming
growth factor b1: cytokine)
2509C/T rs1800469 Taiwanese women (150, 159)
(Hsieh et al., 2005f)
Dutch women (72, 95 or 93)
(van Kaam et al., 2007a)
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.TNF (6p21.3, tumour necrosis
factor a: cytokine)
21031T/C rs1799964 Japanese women: 21031T,
2863C, 2857C haplotype
(123, 165) (Teramoto et al.,
2004)
Japanese women (130, 185)
(Asghar et al., 2004)
Japanese women;
disease severity
(Asghar et al.,
2004)
2863C/A rs1800630 Japanese women: 21031T,
2863C, 2857C haplotype
(123, 165) (Teramoto et al.,
2004)
2857C/T rs1799724 Japanese women: 21031T,
2863C, 2857C haplotype
(123, 165) (Teramoto et al.,
2004)
2308G/A rs1800629 Taiwanese women (120,
106) (Hsieh et al., 2002)
Korean women (70, 202)
(Lee et al., 2002)
Austrian women (92, 69)
(Wieser et al., 2002a)
2238G/A rs361525 Korean women (70, 202)
(Lee et al., 2002)
Austrian women (92, 69)
(Wieser et al., 2002a)
rs1800750, rs3093661,
rs1800610, rs3093662,
rs4645843, rs3093664,
rs3091257
Australian women (958,
959) (Zhao et al., 2007)
TNF (6p21.3, tumour necrosis
factor b (Lymphotoxin-alpha
LTA): cytokine)
Intron 1þ252A/G (A1069G) rs909253 Chinese women (82, 80)
(Luo et al., 2006)
rs2857602, rs2844486,
rs3131637, rs2844484,
rs2844483, rs4647191,
rs2844482, rs2071590,
rs1800683, rs2239704,
rs909253, rs2857713,
rs3093543, rs1041981
Australian women (958,
959)
(Zhao et al., 2007)
TNFRSF1B (1p36.3-p36.2,
tumour necrosis factor receptor
2: cytokine receptor)
p.M196R rs1061622 Japanese women (123, 165)
(Teramoto et al., 2004)
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3HLA-DQB1 genes are in strong linkage disequilibrium (de Bakker et al.,
2006), which may explain why they both show an association with
endometriosis. Studies of Chinese and Korean women investigating
many of the known alleles of the HLA-DRB1 gene found no association
between these alleles and endometriosis susceptibility in these popu-
lations (Wang et al., 2002; Whang et al., 2006). Two polymorphisms
in the cytotoxic T lymphocyte antigen 4 (CTLA-4) gene were found not
to be associated with endometriosis (Vigano et al., 2005).
Regulation upon activation normal T-cell expressed and secreted
Regulation upon Activation Normal T cell Expressed and Secreted
(RANTES, recently renamed CCL5) is an inﬂammatory cytokine that
has been implicated in the induction of monocyte migration in the per-
itoneal ﬂuid of women with endometriosis (Pritts et al., 2002).
Although the 2403G/A and 228C/G polymorphisms in the CCL5
gene and the delta32 and p.V64I polymorphisms in the RANTES
receptor genes, CCR5 and CCR2, respectively, do not appear to
affect endometriosis susceptibility (Antinolo et al., 2003, 2004), the
p.P12A polymorphism in the gene encoding PPAR-g (PPARG), which
regulates the expression of CCL5, has been linked to an increased
risk of endometriosis (Dogan et al., 2004). On the other hand, no
association was found in Japanese women between the PPARG
p.P12A polymorphism and endometriosis, but an association was
found with the exon 6 161C/T polymorphism in that same gene
(Kiyomizu et al., 2006).
Summary
No consistent evidence linking endometriosis with speciﬁc poly-
morphisms of genes coding for inﬂammatory mediators is available.
A number of polymorphisms have been found to be associated with
endometriosis in selected populations (Table I). However, these
associations have not been independently conﬁrmed across ethnic
barriers, either because only single studies are available or because
other studies investigating these polymorphisms reported no associ-
ation. Nor have meta-analyses of these studies been published. There-
fore, no speciﬁc polymorphisms of genes encoding inﬂammatory
mediators have been convincingly shown to play a role in the suscep-
tibility to endometriosis.
Genes involved in sex hormone activity
Investigations of the inﬂuence of polymorphisms in genes encoding sex
hormones and hormone regulators are set out in Table II.
Estrogen receptor
The inﬂuence of estrogen receptor gene (ESR1) polymorphisms has
been investigated both in European and in Asian women with endo-
metriosis. The XbaI (2351A/G) and the PvuII (2397T/C) restriction
fragment-length polymorphisms (RFLPs) were not associated with
endometriosis in a Korean population (Kim et al., 2005b), but
appear to affect endometriosis susceptibility in Taiwanese women
(Hsieh et al., 2007b). The association between endometriosis and
the PvuII RFLP (2397T/C) was also found in Greek and Italian
women (Georgiou et al., 1999; Luisi et al., 2006), and has been
shown to inﬂuence disease severity, but not susceptibility, in
German and Egyptian women (El-Gindi et al., 2002; Renner et al.,
2006). This polymorphism was not found to affect endometriosis sus-
ceptibility in Korean women (Kim et al., 2005b), and studies
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Table II Polymorphisms of genes encoding sex hormones and hormone regulators, which have been investigated for their role in endometriosis
Gene (locus, protein name and its function) Variant Association with susceptibility Phenotype
Name dbSNP
ID
Positive (number of cases,
number of controls)
Negative (number of cases,
number of controls)
AR (Xq11.2-q12, androgen receptor gene:
hormone receptor)
CAG repeat
(exon 1)
Taiwanese women (110, 99) (Hsieh
et al., 2001b)
Italian women (105, 92)
(Lattuada et al., 2004c)
ESR1 (6q25.1, estrogen receptor
a: hormone receptor)
TA repeat
(promoter)
Greek women (57, 57)
(Georgiou et al., 1999)
Taiwanese women (119, 108)
(Hsieh et al., 2005d)
Korean women (180, 165)
(Kim et al., 2005b)
Korean women; disease stage and disease
susceptibility (Kim et al., 2005b)
PvuII RFLP
(2397T/C)
(IVS1
2401T/C)
rs2234693 Greek women (57, 57)
(Georgiou et al., 1999)
Italian women (61
†)
(Luisi et al., 2006)
Japanese women (203, 179)
(Kitawaki et al., 2001)
Taiwanese women (112, 110)
(Hsieh et al., 2007b)
Korean women (180, 165)
(Kim et al., 2005b)
Japanese women (132, 182)
(Wang et al., 2004)
Austrian women (32, 790)
(Huber et al., 2005)
German women (98, 98); disease severity,
haplotype with rs7340799
(Renner et al., 2006)
Egyptian women (23
†); disease severity
(El-Gindi et al., 2002)
XbaI RFLP
(2351A/G)
rs7340799 Taiwanese women (112 EM, 106
LM, 110C) (Hsieh et al., 2007b)
Italian women (61
†) (Luisi et al.,
2006)
Japanese women (132, 182)
(Wang et al., 2004)
Korean women (180, 165)
(Kim et al., 2005b)
German women (98, 98)); disease severity,
haplotype with rs2234693
(Renner et al., 2006)
ESR2 (14q23.2, estrogen receptor
b: hormone receptor)
RsaI RFLP
(1082G/A)
rs1256049 Japanese women (132, 182)
(Wang et al., 2004)
AluI RFLP
(1730A/G)
rs4986938 Japanese women (132, 182)
(Wang et al., 2004)
Italian women (61
†)
(Luisi et al., 2006)
Korean women (239, 287)
(Lee et al., 2007)
Japanese women; disease severity
(Wang et al., 2004)
NRIP1 (21q11.2, receptor interacting protein 140:
estrogen and progesterone receptor cofactor)
p.R448G rs2229742 Spanish women (59, 141)
(Caballero et al., 2005)
PGR (11q22-q23, progesterone receptor:
hormone receptor)
331A/G rs10895068 Dutch women (72, 93)
(van Kaam et al., 2007b)
Dutch women; risk of deep inﬁltrating
endometriosis (van Kaam et al., 2007b)
PROGINS (320 bp PV/HS-1
Alu insertion in intron G and 2
SNPs: rs1042838 in exon 4 and
rs104839 in exon 5)
Austrian women (95, 107)
(Wieser et al., 2002b)
Brazilian women (121, 281)
(De Carvalho et al., 2007) signif.
assoc.
Italian women (131, 127)
(Lattuada et al., 2004a)
Australian European women (980
triads
‡) (Treloar et al., 2005a, b)
Dutch women (72, 93) (van Kaam
et al., 2007b)
Indian women (100, 108)
(Govindan et al., 2007)
Genes are grouped alphabetically, and studies showing positive or negative associations of these genes with disease susceptibility and/or positive associations with phenotype are presented.
†Not a case–control study;
‡Parent–offspring study.
RFLP, restriction fragment-length polymorphism; SNP, single-nucleotide polymorphism.
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5investigating its importance in Japanese women have reported conﬂict-
ing results (Kitawaki et al., 2001; Wang et al., 2004). An Austrian
group investigated the effect of the ESR1 2397T/C polymorphism,
which they named IVS12401T/C, but found no association with
endometriosis susceptibility (Huber et al., 2005). A TA repeat micro-
satellite upstream of the ESR1 gene has been linked to endometriosis
susceptibility in Greek, Taiwanese and Korean women (Georgiou
et al., 1999; Kim et al., 2005b; Hsieh et al., 2005d), and has been
associated with susceptibility to mild endometriosis in Korean
women (Kim et al., 2005b). Studies of Japanese, Korean and Italian
women found no link between the XbaI RFLP (2351A/C) in the
ESR1 gene and endometriosis susceptibility (Wang et al., 2004; Kim
et al., 2005b; Luisi et al., 2006), although a study of German women
suggested that it may inﬂuence lesion severity (Renner et al., 2006).
The AluI RFLP (1730A/G) in the ESR2 gene was linked to an increased
risk of stage IV endometriosis in Japanese women (Wang et al., 2004),
but was not shown to inﬂuence disease susceptibility in groups of
Italian and Korean women (Luisi et al., 2006; Lee et al., 2007).
Progesterone receptor
Groups in Austria, Brazil and Italy have demonstrated a link between
the PROGINS polymorphism in the PGR gene and endometriosis
susceptibility (Wieser et al., 2002b; Lattuada et al., 2004a; De Car-
valho et al., 2007). A study of Dutch women with deep inﬁltrating
endometriosis found no association with PROGINS, but did
observe an association with the PGR 331G/A polymorphism (van
Kaam et al., 2007b). A study from India (Govindan et al., 2007)
and an analysis of pooled data from an Australian group who con-
ducted several studies investigating the PROGINS polymorphism
and ﬁve SNPs in the PGR gene, indicated that there was no associ-
ation with endometriosis susceptibility for any of these variants
(Treloar et al., 2005a).
Androgen receptor
The CAG repeat microsatellite in the AR gene has been linked to an
increased risk of uterine ﬁbroids, and the 21 CAG repeat allele
showed an association with endometriosis susceptibility in Taiwanese
women (Hsieh et al., 2001b). However, an Italian study found no
association between CAG repeat length and endometriosis suscepti-
bility (Lattuada et al., 2004c). Receptor interacting protein 140
co-regulates the activities of estrogen and progesterone receptors
and is essential for female fertility (Caballero et al., 2005). The
p.R448G polymorphism in the gene encoding this protein (NRIP1)
has been linked to endometriosis susceptibility in Spanish women
(Caballero et al., 2005).
Summary
No consistent evidence linking speciﬁc polymorphisms of genes
encoding proteins involved in sex hormone activity with endometriosis
is available. A number of polymorphisms have been found to be
associated with endometriosis in selected populations (Table II).
However, these associations have not been independently conﬁrmed
across ethnic barriers, either because only single studies are available
or because other studies investigating the respective polymorphisms
reported no association. A systematic review and meta-analysis of
studies investigating sex steroid biosynthesis and sex steroid receptors
in women with endometriosis has been published, demonstrating no
consistent association of the investigated polymorphisms with endo-
metriosis (Guo, 2006a). Therefore, no speciﬁc polymorphisms of
genes encoding proteins involved in sex hormone activity have been
convincingly shown to play a role in the susceptibility to
endometriosis.
Metabolic enzymes
17-b hydroxysteroid dehydrogenase type 1
The 17-b hydroxysteroid dehydrogenase type 1 (HSD17B1) gene
encodes a key enzyme involved in testosterone biosynthesis and estro-
gen metabolism. The p.S312G polymorphism in this gene has been
linked to an increased risk of endometriosis in Japanese women (Tsu-
chiya et al., 2005b), and the 227A/C (vIV) polymorphism was associ-
ated with an increased risk of endometriosis in a cohort of Austrian
women (Huber et al., 2005).
Detoxiﬁcation enzymes
The CYP1A1 and CYP1B1 genes encode phase I detoxiﬁcation enzymes
involved in estrogen metabolism. Studies in Austrian, Indian, Chinese,
Japanese and Taiwanese populations found no association between
known polymorphisms in the CYP1A1 gene and susceptibility to endo-
metriosis (Peng et al., 2002; Iizuka et al., 2003; Babu et al., 2005;
Huber et al., 2005; Juo et al., 2006). However, studies in Greece
and the UK indicated that the MspI RFLP (6235T/C) in the CYP1A1
gene may inﬂuence endometriosis susceptibility when associated
with the GSTM1 null deletion variant (Arvanitis et al., 2001, 2003;
Hadﬁeld et al., 2001). Peng et al. (2003a) reported that the
CYP1A1 4889A/G polymorphism is associated with endometriosis
in Chinese women. An Austrian group investigated the p.N453S poly-
morphism in the CYP1B1 gene but this did not appear to inﬂuence sus-
ceptibility to endometriosis (Huber et al., 2005). In a Korean study,
the CYP1B1 p.L432V, Asp(449)C/T and p.A453S polymorphisms
were not associated with late stage endometriosis (Cho et al.,
2007). Polymorphisms in genes encoding other enzymes involved in
estrogen metabolism (COMT) or phase I detoxiﬁcation (myeloperoxi-
dase) have also been investigated, but failed to show an effect on
endometriosis susceptibility (Wieser et al., 2002c; Hsieh et al.,
2004a; Huber et al., 2005; Juo et al., 2006).
The CYP17A1 and CYP19A1 genes both code for enzymes involved
in estrogen biosynthesis. Whereas studies of Taiwanese women have
shown a possible relation between endometriosis susceptibility and
the 234T/C polymorphism in the promoter region of the CYP17A1
gene (Hsieh et al., 2004b, 2005d), no strong association with
CYP17A1 polymorphisms has been found in UK, Brazilian, Austrian,
Taiwanese or Japanese study populations (Kado et al., 2002; Asghar
et al., 2005; Huber et al., 2005; Juo et al., 2006; De Carvalho et al.,
2007). The TTTA repeat microsatellite in the CYP19A1 gene may
increase the risk of endometriosis in Greek women (Arvanitis et al.,
2003), and shows a weak association in Japanese women (Kado
et al., 2002). Another polymorphism in this gene (p.R264C) was
studied in Japanese and Austrian women, but did not appear to inﬂu-
ence endometriosis susceptibility (Huber et al., 2005; Tsuchiya et al.,
2005b).
The GSTM1, GSTP1, GSTT1, NAT1 and NAT2 genes all encode phase
II detoxiﬁcation enzymes. Null deletions in the glutathione-S-transferase
GSTM1 gene have been linked to an increased risk of endometriosis in
106 Tempfer et al.French, Russian, Indian, Chinese and Taiwanese women (Baranova
et al., 1997, 1999; Ivashchenko et al., 2003; Peng et al., 2003b; Hsieh
et al., 2004a; Babu et al., 2005). These null deletions were not shown
to affect endometriosis susceptibility in Korean, Japanese and Australian
study populations (Baxter et al., 2001; Iizuka et al., 2003; Morizane et al.,
2004; Hur et al., 2005), although the Australian study indicated that
GSTM1 null deletion may predispose endometrial lesions to malignant
transformation (Baxter et al., 2001). The p.I105V polymorphism in
the GSTP1 gene is associated with an increased risk of endometriosis
in Turkish women (Ertunc et al., 2005), but does not seem to have
an effect on susceptibility in Korean women (Hur et al., 2005).
Studies conducted in Greece, France, India, UK, Japan and Korea
showed no correlation between the GSTT1 null deletion variant and
endometriosis susceptibility (Baranova et al., 1999; Arvanitis et al.,
2003; Morizane et al., 2004; Babu et al., 2005; Hur et al., 2005),
whereas a study of Russian women did show such an association (Ivash-
chenko et al., 2003). Several studies have investigated the association
between NAT2 polymorphisms and endometriosis susceptibility, but
they reported conﬂicting results (Baranova et al., 1999; Nakago et al.,
2001; Iizuka et al., 2003; Ivashchenko et al., 2003; Babu et al., 2004;
Deguchi et al., 2005; Iskhakova, 2006). One study investigated NAT1
polymorphisms and found no association with endometriosis suscepti-
bility (Deguchi et al., 2005).
The arylhydrocarbon receptor (AhR) and the AhR nuclear translo-
cator (ARNT) are transcription factors that promote the expression of
a number of genes encoding metabolic enzymes (including CYP1A1 and
GST). The action of AhR is suppressed by the AhR repressor (AhRR).
In Japanese women, the p.A185P polymorphism in the AHRR gene has
been shown to confer endometriosis susceptibility and severity, but
polymorphisms in the AHR and ARNT genes did not have an
effect (Tsuchiya et al., 2005a). In a Korean study, concomitant
carriage of the p.A185P polymorphism in the AHRR gene and the
GSTT1 null deletion, but not carriage of AHRR p.A185P, GSTT1 null
deletion or GSTM1 null deletion alone, was associated with endome-
triosis (Kim et al., 2007b). The AHRR p.A185P polymorphism was
not associated with endometriosis in Japanese women (Watanabe
et al., 2001).
Summary
The most solid evidence so far linking speciﬁc polymorphisms to endo-
metriosis comes from studies investigating phase II detoxiﬁcation
enzymes, namely the GSTT1 null deletion variant. A systematic
review and meta-analysis of the GSTM1 and GSTT1 variants demon-
strated a consistent association between GSTT1 polymorphisms and
endometriosis with a moderate effect size. There was a 29% increased
risk of endometriosis in GSTT1 null deletion carriers (Guo, 2005). It
has to be mentioned, however, that there was evidence of publication
bias in this meta-analysis, indicating that the size of the increased risk
associated with the GSTT1 deletion variant may actually be smaller or
non-existent. In addition, a number of polymorphisms have been
found to be associated with endometriosis in selected populations,
e.g. HSD17B1 p.S312G and 227A/C (vIV), CYP1A1 MspI RFLP
(6235T/C), NAT2*5, CYP17A1 234T/C, CYP19A1 TTTA repeat
microsatellite and AHRR p.A185P (Table III). These associations,
however, have not been independently conﬁrmed across ethnic
barriers either because only single studies are available or because
other studies investigating these polymorphisms reported no
association.
Genes regulating vascular function
and tissue remodelling
Endometriosis shows some of the characteristics typically seen in
malignant cells, such as neovascularization and local invasion (Hsieh
et al., 2005c). Therefore, polymorphisms in a number of genes
involved in vascular and cellular growth and reorganization have
been investigated for a possible role in endometriosis.
Vascular endothelial growth factor, epidermal growth factor receptor
and endostatin
Vascular endothelial growth factor (VEGF) mediates vascular per-
meability and angiogenesis, and is known to be a key molecule in
the pathogenesis of endometriosis (Bhanoori et al., 2005a;
Kim et al., 2005a). Three polymorphisms in the VEGF gene have
been evaluated in women with endometriosis. The 405G/C poly-
morphism has been linked to endometriosis susceptibility in South
Indian women, and with susceptibility to advanced-stage endometrio-
sis in Korean women (Bhanoori et al., 2005a; Kim et al., 2005a). In
contrast, the 2460C/T polymorphism did not appear to affect sus-
ceptibility in either of these populations (Bhanoori et al., 2005a; Kim
et al., 2005a), but may inﬂuence the risk of endometriosis in Taiwa-
nese women (Hsieh et al., 2004d). The VEGF 936C/T polymorphism
and the endostatin 4349G/A polymorphism were not associated with
endometriosis in Korean women (Kim et al., 2007a) (Table IV). The
epidermal growth factor receptor (EGFR) is another molecule
involved in angiogenesis, and the EGFR 2073*T allele has been
linked to an increased risk of endometriosis in Taiwanese women
(Hsieh et al., 2005e) (Table I).
Angiotensin-I-converting enzyme
Angiotensin-I-converting enzyme (ACE) catalyzes the conversion of
angiotensin I to angiotensin II, a potent vasoconstrictor. Three poly-
morphisms in the gene encoding this enzyme have been investigated
in Taiwanese women with endometriosis, and both the 2350A/G
and 2240A/T variants as well as the insertion/deletion (I/D) poly-
morphism are associated with endometriosis susceptibility in this
population (Hsieh et al., 2005a, 2007a).
Matrix metalloproteinases
Matrix metalloproteinases (MMPs) are thought to be involved in the
tissue invasion that occurs during endometriotic lesion formation
(Ferrari et al., 2006). Polymorphisms in MMP1, MMP3, MMP7 and
MMP9 genes have been investigated in Chinese women with endome-
triosis. A single I/D polymorphism 1G/2G (also referred to as
21607ins/delG) in the promoter region of the MMP1 gene and the
2181A/G polymorphism in the MMP7 gene were associated with
an increased risk of endometriosis (Kang et al., 2005; Shan et al.,
2006). In contrast, a single I/D polymorphism 21171ins/delA (5A/
6A) in the promoter region of the MMP3 gene did not appear to
affect endometriosis susceptibility (Kang et al., 2005; Shan et al.,
2005). The MMP1(2G)/MMP3(6A) combination showed an
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Table III Polymorphisms of genes encoding enzymes involved in metabolism and biosynthesis, which have been investigated for their role in endometriosis
Gene (locus, protein name and its
function)
Variant Association with susceptibility Phenotype
Name dbSNP ID Positive Negative
AHR (7p15, arylhydrocarbon receptor:
transcription factor, detoxiﬁcation)
p.K554R rs2066853 Japanese women (79, 59)
(Tsuchiya et al., 2005a)
ARNT (7p15, arylhydrocarbon receptor
nuclear translocator: transcription factor,
detoxiﬁcation)
567G/C (p.V189V) rs2228099 Japanese women (79, 59)
(Tsuchiya et al., 2005a)
AHRR (5p15.3, arylhydrocarbon receptor
repressor: transcription factor repressor,
detoxiﬁcation)
p.A185P rs2292596 Japanese women (79, 59) (Tsuchiya et al., 2005a)
Korean women, in association with GSTT1 null
deletion (316, 256) (Kim et al., 2007b)
Japanese women (45, 108)
(Watanabe et al., 2001)
No differences found
Japanese women; disease
severity (79, 59)
(Tsuchiya et al., 2005a)
COMT (22q11.21, catechol-O-methyl
transferase: steroid biosynthesis, Estrogen
metabolism)
p.V158M rs4680 Austrian women (91, 92)
(Wieser et al., 2002c); (32,
790) (Huber et al., 2005)
Taiwanese women (105,
312) ((Juo et al., 2006)
CYP1A1 (15q22-q24, cytochrome P450 1A1
enzyme: steroid biosynthesis, Estrogen
metabolism, phase I detoxiﬁcation)
MspI RFLP (6235T/
C) (3801T/C) (m1)
rs4646903 Greek women; alone or in combination with GSTM1
null deletion (5
†, 54) (Arvanitis et al., 2001); in
combination with GSTM1 null deletion (275, 346)
(Arvanitis et al., 2003; Cretan Greek women)
UK, mainly Caucasian women; in combination with
GSTM1 null deletion (101; 154 þ 192 in sib pair
analysis) (Hadﬁeld et al., 2001)
Chinese women (76, 80)
(Peng et al., 2002)
Taiwanese women of
Chinese descent (105,
312) (Juo et al., 2006)
Austrian women (32, 790)
(Huber et al., 2005)
South Indian women (310,
215) (Babu et al., 2005)
Japanese women (35, 37)
(Iizuka et al., 2003)
p.I462V
4889A/G (m2)
rs1048943 Chinese women (76, 80) (Peng et al., 2003a) Chinese women (76, 80)
(Peng et al., 2002)
CYP1B1 (2p21, cytochrome P450 1B1 enzyme:
steroid biosynthesis, Estrogen metabolism,
phase I detoxiﬁcation)
p.N453S rs1800440 Austrian women (32, 790)
(Huber et al., 2005)
p.L432V,
p.D449D(C/T),
p.N453S, p.A119S
rs1056836,
rs1056837,
rs1800440,
rs1056827
Korean women (221, 188)
(Cho et al., 2007)
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.CYP17A1 (10q24.3, cytochrome P450 17
enzyme: estrogen biosynthesis)
MspA1 RFLP
(234T/C)
rs743572 Taiwanese women (119, 128) (Hsieh et al., 2004b);
(119, 108) (Hsieh et al., 2005d)
Brazilian women (121,
281) (De Carvalho et al.,
2007)
Japanese women (140,
177) (Kado et al., 2002)
UK (94, 97) and Japanese
women (130, 179)
(Asghar et al., 2005)
Austrian women (32, 790)
(Huber et al., 2005)
Taiwanese women (198,
312) (Juo et al., 2006)
CYP19A1 (15q21.1, aromatase: steroid
biosynthesis)
TTTA repeat
microsatellite
Greek women (275, 346) (Arvanitis et al., 2003) Japanese women;
chocolate cysts (140, 177)
(Kado et al., 2002)
p.R264C rs28757190 Austrian women (32, 790)
(Huber et al., 2005)
Japanese women (79, 59)
(Tsuchiya et al., 2005b)
GSTM1 (1p13.3, glutathione-S-transferase M1:
phase II detoxiﬁcation)
Null deletion French women (50, 72)
(Baranova et al., 1997); (65, 72)
(Baranova et al., 1999)
Russian women - in combination with either GSTT1
null mutation homozygots or NAT2 slow acetylator
(*5, *6, *7 homozygots) (74, 40) (Ivashchenko et al.,
2003)
Chinese women (76, 80) (Peng et al., 2003b)
Taiwanese women (150, 159) (Hsieh et al., 2004a)
South Indian women (310, 215) (Babu et al., 2005)
Greek women; in combination with CYP1A1 6235T/C
(5
†, 54) (Arvanitis et al., 2001); (275, 346)
(Arvanitis et al., 2003; Cretan Greek women)
UK, mainly Caucasian women; in combination with
CYP1A1 6235T/C (101; 154 þ 192 in sib pair analysis)
(Hadﬁeld et al., 2001)
Australian women (84,
219) (Baxter et al., 2001)
Japanese women (35, 37)
(Iizuka et al., 2003);
(114, 179) (Morizane et al.,
2004)
Korean women (194, 259)
(Hur et al., 2005)
Korean women (316, 256)
(Kim et al., 2007b)
Australian women (84,
219) (Baxter et al., 2001)
GSTP1 (11q13, glutathione-S-transferase P1:
phase II detoxiﬁcation)
p.I105V rs1695 Turkish women (150, 150) (Ertunc et al., 2005) Korean women (194, 259)
(Hur et al., 2005)
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Table III Continued
Gene (locus, protein name and its
function)
Variant Association with susceptibility Phenotype
Name dbSNP ID Positive Negative
GSTT1 (22q11.23, glutathione-S-transferase
T1: phase II detoxiﬁcation)
Null deletion Korean women, in association with AHRR p.A185P
(316, 256) (Kim et al., 2007b)
Russian women;in combinationwith eitherGSTM1null
mutation homozygots or NAT2 slow acetylator (*5, *6,
*7 homozygots) (74, 40) (Ivashchenko et al., 2003)
French women (65, 72)
(Baranova et al., 1999)
Greek women (275, 346)
(Arvanitis et al., 2003)
South Indian women (310,
215) (Babu et al., 2005)
Korean women (194, 259)
(Hur et al., 2005); no
association)
Japanese women (114,
179) (Morizane et al.,
2004)
UK, mainly Caucasian
women (129, 147)
(Hadﬁeld et al., 2001)
HSD17B1 (17q11-q21, 5 17-b hydroxysteroid
dehydrogenase: testosterone biosynthesis,
Estrogen metabolism)
227A/C (vIV) Austrian women (32, 790) (Huber et al., 2005)
p.S312G rs605059 Japanese women (79, 59) (Tsuchiya et al., 2005b) Japanese women; disease
severity (Tsuchiya et al.,
2005b)
MPO (17q23.1, myeloperoxidase: phase I
detoxiﬁcation, oxidation and activation of
carcinogens and nitric oxide)
2463G/A rs2333227 Taiwanese women (150,
159) (Hsieh et al., 2004a)
NAT1 (8p23.1-p21.3, N-acetyltransferase 1:
phase II detoxiﬁcation)
NAT1*3, *4, *10,
*11
Japanese women (145,
182) (Deguchi et al., 2005)
NAT2 (8p22, N-acetyltransferase 2: phase II
detoxiﬁcation)
Nat2*4-*7 French women NAT2*5 allele (65, 72)
(Baranova et al., 1999)
UK women NAT2*4/NAT2*6 genotype (54, 123)
(Nakago et al., 2001)
Balkan women NAT2*7 allele (102, 153)
(Iskhakova, 2006)
Russian women; slow acetylator (*5, *6, *7
homozygots) in combination with either GSTT1 or
GSTM1 null mutation homozygots (74, 40)
(Ivashchenko et al., 2003)
South Indian women (252,
264) (Babu et al., 2004)
Japanese women (145,
182) (Deguchi et al., 2005);
(35, 37) (Iizuka et al., 2003)
Genes are grouped alphabetically, and studies showing positive or negative associations of these genes with disease susceptibility and/or positive associations with phenotype are presented.
†Affected family members.
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Table IV Polymorphisms encoding genes involved in glucose homeostasis, vascular function and tissue remodelling, which have been investigated for their role
in endometriosis
Gene (locus, protein name and its
function)
Variant Association with susceptibility Phenotype
Name dbSNP ID Positive Negative
Mediators of glucose homeostasis
GALT (9p13, galactose-1-phosphate uridyl
transferase: galactose metabolism)
p.N314D rs2070074 North American women (33,
111) (Cramer et al., 1996)
UK women (148, 148) (Hadﬁeld
et al., 1999); (78, 248 C) (Morland
et al., 1998)
Icelandic women (85 cases, 103
male controls, 110 female
controls) (Stefansson et al., 2001)
Chinese women (325, 310) (He
et al., 2006)
p.Q188R No dbSNP ID (rare mutation) Chinese women (325, 310) (He
et al., 2006)
UK women (78, 248) (Morland
et al., 1998)
PPARG (3p25, peroxisome
proliferator-activated receptor-g:
transcription factor; mediates insulin
resistance, regulates CCL5 expression)
p.P12A rs1801282 German women (51, 55) (Dogan
et al., 2004)
Japanese women (390 women
with endometriosis, leiomyoma or
adenomyoma, 144 controls)
(Kiyomizu et al., 2006)
p.H447H,
161C/T
rs3856806 Japanese women (390 women
with EM, leiomyoma or
adenomyoma, 144 controls)
(Kiyomizu et al., 2006)
Mediators of vascular function or genes linked to cardiovascular risk
ACE (17q23.3, angiotensin-I converting
enzyme: mediates vascular homeostasis)
2240A/T rs4291 Taiwanese women (150, 159)
(Hsieh et al., 2005a)
2350A/G rs4343 Taiwanese women (150, 159)
(Hsieh et al., 2005a)
287 bp ALU
ins/del in intron
16
Several dbSNP IDs: rs4646994 or rs4340,
rs1799752
Taiwanese women (125
endometriosis, 120 leiomyoma,
128 control) (Hsieh et al.,
2007a)
COL18A1 (21q22.3, endostatin: inhibits
endothelial cell proliferation and
angiogenesis)
4349G/A
(p.D1437 N)
(p.D104 N)
rs12483377 Korean women (105, 100 þ 100)
(Kim et al., 2007a)
VEGFA (6p12, vascular endothelial growth
factor: mediates vascular permeability and
angiogenesis)
405G/C
(2634G/C)
Rs2010963 South Indian women (215, 210)
(Bhanoori et al., 2005a)
Korean women (215, 219 þ 70)
(Kim et al., 2005a)
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Table IV Continued
Gene (locus, protein name and its
function)
Variant Association with susceptibility Phenotype
Name dbSNP ID Positive Negative
2460C/T Rs833061 Taiwanese women (122, 131)
(Hsieh et al., 2004d)
South Indian women (215, 210)
(Bhanoori et al., 2005a)
Korean women (215, 219 þ 70)
(Kim et al., 2005a)
936C/T rs3025039 Korean women (105, 100 þ 100)
(Kim et al., 2007a)
Genes involved in tissue remodelling
AHSG (3q27, alpha 2-Heremans Schmidt
glycoprotein: mediates tissue development)
p.T230M rs4917 Korean women (79, 105) (Kim
et al., 2004)
p.T238S rs4918 Korean women (79, 105) (Kim
et al., 2004)
MMP1 (11q22.3, matrix
metalloproteinase-1: tissue remodelling)
21607ins/
delG (1G/2G)
rs112925 Chinese women: 2G allele (100,
150) (Kang et al., 2005)
North China population
(100,150) (Shan et al., 2005)
Italian women (56, 71) (Ferrari
et al., 2006)
MMP3 (11q22.3, matrix
metalloproteinase-3: tissue remodelling)
21171ins/
delA (5A/6A)
Chinese women MMP1-2G
MMP3-6A haplotype (100, 150)
(Kang et al., 2005; Shan et al.,
2005)
Chinese women (100, 150) (Kang
et al., 2005)
North China population (100,150)
(Shan et al., 2005)
Italian women (56, 71) (Ferrari
et al., 2006)
MMP7 (11q21-q22, matrix
metalloproteinase-7: tissue remodelling)
2181A/G rs1799750 Chinese women (143 EM, 76
AM, 160) (Shan et al., 2006)
MMP9 (20q11.2-q13.1, matrix
metalloproteinase-9: tissue remodelling)
21562C/T rs3918242 Chinese women (143 EM, 76 AM)
(Shan et al., 2006)
SERPINE1 (7q21.3–q22, plasminogen
activator inhibitor-1: ﬁbrinolysis system.
Linked to cardiovascular disease)
2675ins/delG
(4G/5G)
Several dbSNP IDs: rs1799768, rs34857375,
rs1799762, rs1799889
Canadian and North American
women (75, 43) (Bedaiwy et al.,
2006)
Genes involved in signal transduction
EMX2 (10q26.1, empty spiracles homeobox
2: homeodomain transcription factor)
rs1860399, rs82 613, rs82 612, rs242956,
rs703409, rs703411, rs1638626, rs2286629,
rs385209, rs855769, rs365446, rs8192640,
rs740734, rs855768, rs2240776, rs703413,
rs4751627, rs242960, rs8181280, rs855766,
rs4752078, rs4752079
Australian women 768, 768)
(Treloar et al., 2007)
STAT6 (12q13, signal transducer and
activator of transcription 6: signal
transduction and activation of transcription)
2964G/A rs324015 South Indian women (232, 210)
(Bhanoori et al., 2007)
Genes involved in malignant transformation
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.association (Kang et al., 2005; Shan et al., 2005), but this is probably
due to the effects of the MMP1 (2G) genotype rather than a combined
effect of both genes. The 21562C/T polymorphism in the MMP9
gene was not associated with endometriosis susceptibility (Shan
et al., 2006). A group that investigated MMP polymorphisms in a popu-
lation of Italian women found no association between MMP1 or
MMP3 gene polymorphisms and susceptibility to endometriosis
(Ferrari et al., 2006).
a2-HS glycoprotein, plasminogen activator inhibitor-1
a2-HS glycoprotein (AHSG) has been implicated in tissue develop-
ment, and polymorphisms in the AHSG gene (p.T230M and
p.T238S) have been linked to endometriosis susceptibility in
Korean women (Kim et al., 2004). The plasminogen activator
inhibitor 1 (PAI-1) 4G/5G promoter polymorphism has been
investigated in 75 women with laparoscopically conﬁrmed endo-
metriosis and 43 controls (Bedaiwy et al., 2006). In this study,
the 4G/4G genotype, known to be associated with hypoﬁbrinolysis,
was found to be over-represented among women with
endometriosis.
Summary
No consistent evidence linking speciﬁc polymorphisms of genes
endoding proteins involved in vascular function and tissue remodelling
with endometriosis is available. A number of polymorphisms have
been found to be associated with endometriosis in selected popu-
lations (Table IV). These associations, however, have not been inde-
pendently conﬁrmed across ethnic barriers either because only
single studies are available or because other studies investigating
these polymorphisms reported no association. No meta-analysis of
respective studies has been published. Therefore, no speciﬁc poly-
morphisms of genes encoding proteins involved in vascular function
and tissue remodelling have been convincingly shown to play a role
in the susceptibility to endometriosis.
Other genes linked to endometriosis
Genes involved in signal transduction (STAT6, Table IV), malignant
transformation (TP53, P21, KRAS, Table IV; BRAF), apoptosis (FAS,
Table I; FASLG, Table I) and galactose metabolism (GAL T,Table IV)
have been investigated for a role in endometriosis susceptibility, but
no consistent association has been found (Tables I–IV) (Cramer
et al., 1996; Morland et al., 1998; Hadﬁeld et al., 1999; Hsieh et al.,
2001c; Stefansson et al., 2001; Chang et al., 2002; Lattuada et al.,
2004b; Omori et al., 2004; Fernandez et al., 2005; He et al., 2006;
Hsieh and Lin, 2006; Zhao et al., 2006; Bhanoori et al., 2007; Vietri
et al., 2007). Two exceptions are the STAT6 30-UTR 2964G/A poly-
morphism (Bhanoori et al., 2007) and the GALT p.N314D polymorph-
ism (Cramer et al., 1996), which are over-represented among South
Indian women and US women with endometriosis, respectively.
Hsieh and Lin (2006) found that the TP53 codon p.R72P polymorph-
ism was associated with endometriosis in Taiwanese women and also
looked for the presence of mutations at codons 11 and 248 in this
population, but did not ﬁnd any (Table I). An Australian study of 22
polymorphisms in the EMX2 gene and 15 polymorphisms in the
PTEN gene found no association with endometriosis (Treloar et al.,
2007).
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Polymorphisms and endometriosis 113Summary
No consistent and independently conﬁrmed evidence linking speciﬁc
polymorphisms of the STAT6, TP53, P21, FAS, FASLG, EMX2, PTEN,
CTLA4 and GALT genes is available.
Discussion
In this review, we have summarized the current evidence linking
genetic polymorphisms and endometriosis, showing that the majority
of polymorphisms investigated so far are not associated with this
disease in a methodologically reliable way. This may be because
they have been investigated in only a single study or a limited
number of studies, or because conﬂicting results were obtained.
The most solid evidence to date linking speciﬁc polymorphisms to
endometriosis comes from studies investigating phase II detoxiﬁcation
enzymes. A systematic review and meta-analysis of studies investi-
gating the glutathione-S-transferases GSTM1 and GSTT1 variants
demonstrated a consistent association of a GSTT1 polymorphism
and endometriosis, with a 29% increased risk of endometriosis in
GSTT1 null deletion carriers.
There is no consistent evidence to link speciﬁc polymorphisms of
genes encoding inﬂammatory mediators and proteins involved in sex
steroid metabolism, vascular function and tissue remodelling with
endometriosis. Although a number of polymorphisms have been
found associated with endometriosis in selected populations, these
associations have not been independently conﬁrmed across ethnic
barriers, either because only single studies are available or because
other studies reported no association. The majority of polymorphisms
have not been subjected to meta-analysis due to the limited availability
of comparable studies. However, a systematic review and
meta-analysis of sex steroid biosynthesis and sex steroid receptors
demonstrated no consistent association of the investigated poly-
morphisms with endometriosis.
Clearly, absence of evidence of an association between a speciﬁc
polymorphism and endometriosis does not rule out that this gene in
general or other polymorphisms of this gene in particular may be
involved in the etiology of this disease.
To date, most studies are retrospective genetic association studies,
whereas others are studies with prospectively identiﬁed cases. This is a
potential source of inconsistency, since studies including prospectively
identiﬁed cases, i.e. incident cases, may produce different results com-
pared with studies using retrospectively identiﬁed cases, i.e. prevalent
cases. Other problems facing researchers in this ﬁeld are well-
illustrated in two recent reviews on the genetics of endometriosis
(Guo, 2006a, b). The author ruled out many of the previous positive
ﬁndings, highlighting issues such as lack of independent conﬁrmation
for many studies (Guo, 2006b) and faulty analyses (Guo, 2006a).
In order to further explore the importance of known and new poly-
morphisms in female reproductive function, it is essential that studies
are well-designed and sufﬁciently powered. Whereas retrospective
studies are useful for generating hypotheses, a prospective design
must be used to test these hypotheses. Exploratory (hypothesis-
generating) studies should aim to screen large numbers of genetic vari-
ations. This becomes an option for more researchers as high-
throughput genotyping technologies improve and become more
widely accessible. The exploratory phase should be followed by
validation of a limited number of candidate markers (hypothesis
testing), and prospective studies should be conducted whenever an
association is conﬁrmed. This approach will allow the identiﬁcation
and validation of polymorphisms, and those with strong links to sus-
ceptibility may help in developing new drugs or regimens. In addition,
the discovery of genes that inﬂuence treatment response may enable
individualized treatment to be tailored on the basis of genotype.
Funding
The preparation of this manuscript was sponsored by an unrestricted
educational grant from Merck Serono, Geneva, Switzerland.
Acknowledgements
The authors would like to thanks Drs Polly Field, Imogen Horsey and
Kay Elder for their assistance in drafting the manuscript.
References
Agic A, Xu H, Finas D, Banz C, Diedrich K, Hornung D. Is endometriosis
associated with systemic subclinical inﬂammation? Gynecol Obstet Invest
2006;62:139–147.
Antinolo G, Fernandez RM, Noval JA, Garcia-Lozano JC, Borrego S,
Marcos I, Molini JL. Evaluation of germline sequence variants within
the promoter region of RANTES gene in a cohort of women with
endometriosis from Spain. Mol Hum Reprod 2003;9:491–495.
Antinolo G, Fernandez RM, Noval JA, Molini JL, Borrego S. Analysis of the
involvement of CCR5-Delta32 and CCR2-V64I variants in the
development of endometriosis. Mol Hum Reprod 2004;10:155–157.
Arvanitis DA, Goumenou AG, Matalliotakis IM, Koumantakis EE,
Spandidos DA. Low-penetrance genes are associated with increased
susceptibility to endometriosis. Fertil Steril 2001;76:1202–1206.
Arvanitis DA, Koumantakis GE, Goumenou AG, Matalliotakis IM,
Koumantakis EE, Spandidos DA. CYP1A1, CYP19, and GSTM1
polymorphisms increase the risk of endometriosis. Fertil Steril 2003;
79(Suppl 1):702–709.
Asghar T, Yoshida S, Kennedy S, Negoro K, Zhuo W, Hamana S,
Motoyama S, Nakago S, Barlow D, Maruo T. The tumor necrosis
factor-alpha promoter—1031C polymorphism is associated with
decreased risk of endometriosis in a Japanese population. Hum Reprod
2004;19:2509–2514.
Asghar T, Yoshida S, Nakago S, Morizane M, Ohara N, Motoyama S,
Kennedy S, Barlow D, Maruo T. Lack of association between
endometriosis and the CYP17 MspA1 polymorphism in UK and
Japanese populations. Gynecol Endocrinol 2005;20:59–63.
Babu KA, Rao KL, Reddy NG, Kanakavalli MK, Zondervan KT,
Deenadayal M, Singh A, Shivaji S, Kennedy S. N-acetyl transferase 2
polymorphism and advanced stages of endometriosis in South Indian
women. Reprod Biomed Online 2004;9:533–540.
Babu KA, Reddy NG, Deendayal M, Kennedy S, Shivaji S. GSTM1, GSTT1
and CYP1A1 detoxiﬁcation gene polymorphisms and their relationship
with advanced stages of endometriosis in South Indian women.
Pharmacogenet Genomics2005;15:167–172.
Baranova H, Bothorishvilli R, Canis M, Albuisson E, Perriot S,
Glowaczower E, Bruhat MA, Baranov V, Malet P. Glutathione
S-transferase M1 gene polymorphism and susceptibility to
endometriosis in a French population. Mol Hum Reprod 1997;
3:775–780.
114 Tempfer et al.Baranova H, Canis M, Ivaschenko T, Albuisson E, Bothorishvilli R,
Baranov V, Malet P, Bruhat MA. Possible involvement of arylamine
N-acetyltransferase 2, glutathione S-transferases M1 and T1 genes in
the development of endometriosis. Mol Hum Reprod 1999;5:636–641.
Baxter SW, Thomas EJ, Campbell IG. GSTM1 null polymorphism and
susceptibility to endometriosis and ovarian cancer. Carcinogenesis
2001;22:63–65.
Bedaiwy MA, Falcone T, Mascha EJ, Casper RF. Genetic polymorphism in
the ﬁbrinolytic system and endometriosis. Obstet Gynecol 2006;108:
162–168.
Bhanoori M, Arvind BK, Pavankumar Reddy NG, Lakshmi RK,
Zondervan K, Deenadayal M, Kennedy S, Shivaji S. The vascular
endothelial growth factor (VEGF) þ405G.C5 0-untranslated region
polymorphism and increased risk of endometriosis in South Indian
women: a case control study. Hum Reprod 2005a;20:1844–1849.
Bhanoori M, Babu KA, Deenadayal M, Kennedy S, Shivaji S. The
interleukin-6 -174G/C promoter polymorphism is not associated with
endometriosis in South Indian women. J Soc Gynecol Investig 2005b;
12:365–369.
Bhanoori M, Deenadayal M, Kennedy S, Shivaji S. The G2964A
30-untranslated region polymorphism of the signal transducer and
activator of transcription 6 gene is associated with endometriosis in
South Indian women. Hum Reprod 2007;22:1026–1030.
Billington BP. Gastric cancer; relationships between ABO blood-groups,
site, and epidemiology. Lancet 1956;271:859–862.
Bischoff F, Simpson JL. Genetic basis of endometriosis. Ann NY Acad Sci
2004;1034:284–299.
Caballero V, Ruiz R, Sainz JA, Cruz M, Lopez-Nevot MA, Galan JJ, Real LM,
de CF, Lopez-Villaverde V, Ruiz A. Preliminary molecular genetic
analysis of the Receptor Interacting Protein 140 (RIP140) in women
affected by endometriosis. J Exp Clin Assist Reprod 2005;2:11.
Chang CC, Hsieh YY, Tsai FJ, Tsai CH, Tsai HD, Lin CC. The proline form
of p53 codon 72 polymorphism is associated with endometriosis. Fertil
Steril 2002;77:43–45.
Cho YJ, Hur SE, Lee JY, Song IO, Moon HS, Koong MK, Chung HW. Single
nucleotide polymorphisms and haplotypes of the genes encoding the
CYP1B1 in Korean women: no association with advanced
endometriosis. J Assist Reprod Genet 2007;24:271–277.
Cramer DW, Hornstein MD, Ng WG, Barbieri RL. Endometriosis
associated with the N314D mutation of galactose-1-phosphate uridyl
transferase (GALT). Mol Hum Reprod 1996;2:149–152.
D’Amora P, Sato H, Girao MJ, Silva ID, Schor E. Polymorphisms in exons
1B and 1C of the type I interleukin-1 receptor gene in patients with
endometriosis. Am J Reprod Immunol 2006;56:178–184.
de Bakker PI, McVean G, Sabeti PC, Miretti MM, Green T, Marchini J,
Ke X, Monsuur AJ, Whittaker P, Delgado M et al. A high-resolution
HLA and SNP haplotype map for disease association studies in the
extended human MHC. Nat Genet 2006;38:1166–1172.
De Carvalho CV, Nogueira-De-Souza NC, Costa AM, Baracat EC,
Girao MJ, D’Amora P, Schor E, da S I. Genetic polymorphisms of
cytochrome P450cl7alpha (CYP17) and progesterone receptor genes
(PROGINS) in the assessment of endometriosis risk. Gynecol
Endocrinol 2007;23:29–33.
Deguchi M, Yoshida S, Kennedy S, Ohara N, Motoyama S, Maruo T. Lack
of association between endometriosis and N-acetyl transferase 1
(NAT1) and 2 (NAT2) polymorphisms in a Japanese population. J Soc
Gynecol Investig 2005;12:208–213.
Di W, Guo SW. The search for genetic variants predisposing women to
endometriosis. Curr Opin Obstet Gynecol 2007;19:395–401.
Dogan S, Machicao F, Wallwiener D, Haering HU, Diedrich K, Hornung D.
Association of peroxisome proliferator-activated receptor gamma 2
Pro-12-Ala polymorphism with endometriosis. Fertil Steril 2004;
81:1411–1413.
El-Gindi E, El-Adawy AR, Faris M, El-Moghazy D, El-Hamshary M. Genetic
polymorphism in endometriosis among infertile Egyptian women. Middle
East Fert Soc J 2002;7:44–47.
Ertunc D, Aban M, Tok EC, Tamer L, Arslan M, Dilek S.
Glutathione-S-transferase P1 gene polymorphism and susceptibility to
endometriosis. Hum Reprod 2005;20:2157–2161.
Escobar-Morreale HF, Luque-Ramirez M, San Millan JL. The
molecular-genetic basis of functional hyperandrogenism and the
polycystic ovary syndrome. Endocr Rev 2005;26:251–282.
Falconer H, D’Hooge T, Fried G. Endometriosis and genetic
polymorphisms. Obstet Gynecol Surv 2007;62:616–628.
Fernandez RM, Noval JA, Garcia-Lozano JC, Borrego S, Molini JL,
Antinolo G. Polymorphisms in the promoter regions of FAS and FASL
genes as candidate genetic factors conferring susceptibility to
endometriosis. Int J Mol Med 2005;15:865–869.
Ferrari MM, Biondi ML, Rossi G, Grijuela B, Gaita S, Perugino G, Vigano P.
Analysis of two polymorphisms in the promoter region of matrix
metalloproteinase 1 and 3 genes in women with endometriosis. Acta
Obstet Gynecol Scand 2006;85:212–217.
Ferreira PM, Catarino R, Pereira D, Matos A, Pinto D, Coelho A, Lopes C,
Medeiros R. Cervical cancer and CYP2E1 polymorphisms:
implications for molecular epidemiology. Eur J Clin Pharmacol 2006;
62:15–21.
Georgiou I, Syrrou M, Bouba I, Dalkalitsis N, Paschopoulos M,
Navrozoglou I, Lolis D. Association of estrogen receptor gene
polymorphisms with endometriosis. Fertil Steril 1999;72:164–166.
Goswami D, Conway GS. Premature ovarian failure. Hum Reprod Update
2005;11:391–410.
Govindan S, Ahmad SN, Vedicherla B, Kodati V, Jahan P, Rao KP,
Ahuja YR, Hasan Q. Association of progesterone receptor gene
polymorphism (PROGINS) with endometriosis, uterine ﬁbroids and
breast cancer. Cancer Biomark 2007;3:73–78.
Guo S-W. Glutathione S-transferases M1/T1 gene polymorphisms and
endometriosis: A meta-analysis of genetic association studies. Mol
Hum Reprod 2005;11:729–743.
Guo S-W. Association of endometriosis risk and genetic polymorphisms
involving sex steroid biosynthesis and their receptors: a meta-analysis.
Gynecol Obstet Invest 2006a;61:90–105.
Guo S-W. The association of endometriosis risk and genetic
polymorphisms involving dioxin detoxiﬁcation enzymes: a systematic
review. Eur J Obstet Gynecol Repro Biol 2006b;124:134–143.
Hadﬁeld RM, Manek S, Nakago S, Mukherjee S, Weeks DE, Mardon HJ,
Barlow DH, Kennedy SH. Absence of a relationship between
endometriosis and the N314D polymorphism of galactose-1-phosphate
uridyl transferase in a UK population. Mol Hum Reprod 1999;5:
990–993.
Hadﬁeld RM, Manek S, Weeks DE, Mardon HJ, Barlow DH, Kennedy SH.
Linkage and association studies of the relationship between
endometriosis and genes encoding the detoxiﬁcation enzymes
GSTM1, GSTT1 and CYP1A1. Mol Hum Reprod 2001;7:1073–1078.
Halis G, Arici A. Endometriosis and inﬂammation in infertility. Ann N Y
Acad Sci 2004;1034:300–315.
He C, Song Y, He X, Zhang W, Liao L. No association of endometriosis
with galactose-1-phosphate uridyl transferase mutations in a Chinese
population. Environ Mol Mutagen 2006;47:307–309.
Hsieh YY, Chang CC, Tsai FJ, Wu JY, Shi YR, Tsai HD, Tsai CH.
Polymorphisms for interleukin-1 beta (IL-1 beta)-511 promoter, IL-1
beta exon 5, and IL-1 receptor antagonist: nonassociation with
endometriosis. J Assist Reprod Genet 2001a;18:506–511.
Polymorphisms and endometriosis 115Hsieh YY, Chang CC, Tsai FJ, Wu JY, Tsai CH, Tsai HD. Androgen
receptor trinucleotide polymorphism in endometriosis. Fertil Steril
2001b;76:412–413.
Hsieh YY, Tsai FJ, Chang CC, Chen WC, Tsai CH, Tsai HD, Lin CC. p21
gene codon 31 arginine/serine polymorphism: non-association with
endometriosis. J Clin Lab Anal 2001c;15:184–187.
Hsieh YY, Chang CC, Tsai FJ, Hsu Y, Tsai HD, Tsai CH. Polymorphisms
for interleukin-4 (IL-4) -590 promoter, IL-4 intron3, and tumor
necrosis factor alpha -308 promoter: non-association with
endometriosis. J Clin Lab Anal 2002;16:121–126.
Hsieh YY, Chang CC, Tsai FJ, Lin CC, Tai CT, Ho M. Association of an A
allele for interleukin-10 -627 gene promoter polymorphism with higher
susceptibility to endometriosis. J Reprod Med 2003;48:735–738.
Hsieh YY, Chang CC, Tsai FJ, Lin CC, Chen JM, Tsai CH. Glutathione
S-transferase M1*null genotype but not myeloperoxidase promoter
G-463A polymorphism is associated with higher susceptibility to
endometriosis. Mol Hum Reprod 2004a;10:713–717.
Hsieh YY, Chang CC, Tsai FJ, Lin CC, Tsai CH. Cytochrome
P450c17alpha 50-untranslated region *T/C polymorphism in
endometriosis. J Genet 2004b;83:189–192.
Hsieh YY, Chang CC, Tsai FJ, Peng CT, Yeh LS, Lin CC. Insulin-like growth
factor II gene Apa I polymorphism is not associated with endometriosis
susceptibility. Genet Mol Biol 2004c;27:165–166.
Hsieh YY, Chang CC, Tsai FJ, Yeh LS, Lin CC, Peng CT. T allele for VEGF
gene-460 polymorphism at the 50-untranslated region: association with a
higher susceptibility to endometriosis. J Reprod Med 2004d;49:468–472.
Hsieh YY, Chang CC, Tsai FJ, Hsu CM, Lin CC, Tsai CH. Angiotensin
I-converting enzyme ACE 2350*G and ACE-240*T-related genotypes
and alleles are associated with higher susceptibility to endometriosis.
Mol Hum Reprod 2005a;11:11–14.
Hsieh YY, Chang CC, Tsai FJ, Hsu CM, Lin CC, Tsai CH. Interleukin-2
receptor beta (IL-2R beta)-627*C homozygote but not IL-12R beta 1
codon 378 or IL-18 105 polymorphism is associated with higher
susceptibility to endometriosis. Fertil Steril 2005b;84:510–512.
Hsieh YY, Chang CC, Tsai FJ, Hsu CM, Lin CC, Tsai CH. The cuttable
C-related genotype and allele for the E-cadherin 30-UTR Pm/l
polymorphism are associated with higher susceptibility to
endometriosis. Genet Mol Biol 2005c;28:661–664.
Hsieh YY, Chang CC, Tsai FJ, Lin CC, Tsai CH. Estrogen receptor alpha
dinucleotide repeat and cytochrome P450c17alpha gene
polymorphisms are associated with susceptibility to endometriosis.
Fertil Steril 2005d;83:567–572.
Hsieh YY, Chang CC, Tsai FJ, Lin CC, Tsai CH. T homozygote and allele of
epidermal growth factor receptor 2073 gene polymorphism are
associated with higher susceptibility to endometriosis and
leiomyomas. Fertil Steril 2005e;83:796–799.
Hsieh YY, Chang CC, Tsai FJ, Peng CT, Yeh LS, Lin CC. Polymorphism for
transforming growth factor beta 1-509 (TGF-B1-509): association with
endometriosis. Biochem Genet 2005f;43:203–210.
Hsieh YY, Lin CS. P53 codon 11, 72, and 248 gene polymorphisms in
endometriosis. Int J Biol Sci 2006;2:188–193.
Hsieh YY, Lee CC, Chang CC, Wang YK, Yeh LS, Lin CS. Angiotensin
I-converting enzyme insertion-related genotypes and allele are
associated with higher susceptibility of endometriosis and leiomyoma.
Mol Reprod Dev 2007a;74:808–814.
Hsieh YY, Wang YK, Chang CC, Lin CS. Estrogen receptor alpha-351
XbaI*G and -397 PvuII*C-related genotypes and alleles are associated
with higher susceptibilities of endometriosis and leiomyoma. Mol Hum
Reprod 2007b;13:117–122.
Huber A, Keck CC, Heﬂer LA, Schneeberger C, Huber JC, Bentz EK,
Tempfer CB. Ten estrogen-related polymorphisms and endometriosis:
a study of multiple gene-gene interactions. Obstet Gynecol 2005;
106:1025–1031.
Hur SE, Lee JY, Moon HS, Chung HW. Polymorphisms of the genes
encoding the GSTM1, GSTT1 and GSTP1 in Korean women: no
association with endometriosis. Mol Hum Reprod 2005;11:15–19.
Iizuka S, Kosugi Y, Isaka K, Takayama M. Could polymorphisms of
N-acetyltransferase 2 (NAT2), glutathione S-transferase M1 (GSTM1), and
cytochrome P450 (CYP1A1) be responsible for genetic predisposition to
endometriosis among Japanese? J Tokyo Med Univ 2003;61:59–66.
Ishii K, Takakuwa K, Mitsui T, Tanaka K. Studies on the human leukocyte
antigen-DR in patients with endometriosis: genotyping of HLA-DRB1
alleles. Hum Reprod 2002;17:560–563.
Ishii K, Takakuwa K, Kashima K, Tamura M, Tanaka K. Associations
between patients with endometriosis and HLA class II; the analysis of
HLA-DQB1 and HLA-DPB1 genotypes. Hum Reprod 2003;18:985–989.
Iskhakova GMA. Polymorphism of the arylamine-N-acetyltransferase gene
in endometriosis patients in the Republic of Bashkortostan. Balkan J Med
Genet 2006;9:55–60.
Ivashchenko TE, Shved NI, Kramareva NA, Ailamazian EK, Baranov VS.
Analysis of the polymorphic alleles of genes encoding phase 1 and
phase 2 detoxication enzymes in patients with endometriosis.
Genetika 2003;39:525–529.
Juo SH, Wang TN, Lee JN, Wu MT, Long CY, Tsai EM. CYP17, CYP1A1
and COMT polymorphisms and the risk of adenomyosis and
endometriosis in Taiwanese women. Hum Reprod 2006;21:1498–1502.
Kado N, Kitawaki J, Obayashi H, Ishihara H, Koshiba H, Kusuki I,
Tsukamoto K, Hasegawa G, Nakamura N, Yoshikawa T et al. Association
of the CYP17 gene and CYP19 gene polymorphisms with risk of
endometriosis in Japanese women. Hum Reprod 2002;17:897–902.
Kang S, Wang Y, Zhang JH, Jin X, Fang SM, Li Y. Single nucleotide
polymorphism in the matrix metalloproteinases promoter is
associated with susceptibility to endometriosis and adenomyosis.
Zhonghua Fu Chan Ke Za Zhi 2005;40:601–604.
Kennedy S, Bennett S, Weeks DE. Affected sib-pair analysis in
endometriosis. Hum Reprod Update 2001;7:411–418.
Kim JG, Kim H, Ku SY, Kim SH, Choi YM, Moon SY. Association between
human alpha 2-Heremans Schmidt glycoprotein (AHSG) polymorphism
and endometriosis in Korean women. Fertil Steril 2004;82:1497–1500.
Kim SH, Choi YM, Choung SH, Jun JK, Kim JG, Moon SY. Vascular
endothelial growth factor gene þ405 C/G polymorphism is
associated with susceptibility to advanced stage endometriosis. Hum
Reprod 2005a;20:2904–2908.
Kim SH, Choi YM, Jun JK, Kim SH, Kim JG, Moon SY. Estrogen receptor
dinucleotide repeat polymorphism is associated with minimal or mild
endometriosis. Fertil Steril 2005b;84:774–777.
Kim JG, Kim JY, Jee BC, Suh CS, Kim SH, Choi YM. Association between
endometriosis and polymorphisms in endostatin and vascular
endothelial growth factor and their serum levels in Korean women.
Fertil Steril 2007a;89:243–245.
Kim SH, Choi YM, Lee GH, Hong MA, Lee KS, Lee BS, Kim JG, Moon SY.
Association between susceptibility to advanced stage endometriosis and
the genetic polymorphisms of aryl hydrocarbon receptor repressor and
glutathione-S-transferase T1 genes. Hum Reprod 2007b;22:1866–1870.
Kitawaki J, Obayashi H, Ishihara H, Koshiba H, Kusuki I, Kado N,
Tsukamoto K, Hasegawa G, Nakamura N, Honjo H. Oestrogen
receptor-alpha gene polymorphism is associated with endometriosis,
adenomyosis and leiomyomata. Hum Reprod 2001;16:51–55.
Kitawaki J, Obayashi H, Ohta M, Kado N, Ishihara H, Koshiba H, Kusuki I,
Tsukamoto K, Hasegawa G, Nakamura N et al. Genetic contribution of
the interleukin-10 promoter polymorphism in endometriosis
susceptibility. Am J Reprod Immunol 2002;47:12–18.
116 Tempfer et al.Kitawaki J, Koshiba H, Kitaoka Y, Teramoto M, Hasegawa G,
Nakamura N, Yoshikawa T, Ohta M, Obayashi H, Honjo H.
Interferon-gamma gene dinucleotide (CA) repeat and interleukin-4
promoter region (-590C/T) polymorphisms in Japanese patients with
endometriosis. Hum Reprod 2004;19:1765–1769.
Kitawaki J, Kiyomizu M, Obayashi H, Ohta M, Ishihara H, Hasegawa G,
Nakamura N, Yoshikawa T, Honjo H. Synergistic effect of interleukin-6
promoter (IL6 -634C/G) and intercellular adhesion molecule-1 (ICAM-1
469K/E) gene polymorphisms on the risk of endometriosis in Japanese
women. Am J Reprod Immunol 2006;56:267–274.
Kiyomizu M, Kitawaki J, Obayashi H, Ohta M, Koshiba H, Ishihara H,
Honjo H. Association of two polymorphisms in the peroxisome
proliferator-activated receptor-gamma gene with adenomyosis,
endometriosis, and leiomyomata in Japanese women. J Soc Gynecol
Investig 2006;13:372–377.
Lattuada D, Somigliana E, Vigano P, Candiani M, Pardi G, Di Blasio AM.
Genetics of endometriosis: a role for the progesterone receptor gene
polymorphism PROGINS? Clin Endocrinol (Oxf) 2004a;61:190–194.
Lattuada D, Vigano P, Somigliana E, Abbiati A, Candiani M, Di Blasio AM.
Analysis of the codon 72 polymorphism of the TP53 gene in patients
with endometriosis. Mol Hum Reprod 2004b;10:651–654.
Lattuada D, Vigano P, Somigliana E, Odorizzi MP, Vignali M, Di Blasio AM.
Androgen receptor gene cytosine, adenine, and guanine trinucleotide
repeats in patients with endometriosis. J Soc Gynecol Investig 2004c;
11:237–240.
Layman LC. Editorial: BMP15—the ﬁrst true ovarian determinant gene on
the X-chromosome? J Clin Endocrinol Metab 2006;91:1673–1676.
Lee MK, Park AJ, Kim DH. Tumor necrosis factor-alpha and interleukin-6
promoter gene polymorphisms are not associated with an increased risk
of endometriosis. Fertil Steril 2002;77:1304–1305.
Lee GH, Kim SH, Choi YM, Suh CS, Kim JG, Moon SY. Estrogen receptor
beta gene þ1730 G/A polymorphism in women with endometriosis.
Fertil Steril 2007;88:785–788.
Levanat S, Musani V, Komar A, Oreskovic S. Role of the hedgehog/
patched signaling pathway in oncogenesis: a new polymorphism in the
PTCH gene in ovarian ﬁbroma. Ann N Y Acad Sci 2004;1030:134–143.
Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN.
Meta-analysis of genetic association studies supports a contribution of
common variants to susceptibility to common disease. Nat Genet
2003;33:177–182.
Luisi S, Galleri L, Marini F, Ambrosini G, Brandi ML, Petraglia F. Estrogen
receptor gene polymorphisms are associated with recurrence of
endometriosis. Fertil Steril 2006;85:764–766.
Luo M, He YL, Zhang HB, Shen DX, Zong LL, Guan T. Association of
tumor necrosis factors-beta gene polymorphism with endometriosis in
women in Guangdong Province. Nan Fang Yi Ke Da Xue Xue Bao
2006;26:1163–1165.
Modugno F. Ovarian cancer and polymorphisms in the androgen and
progesterone receptor genes: a HuGE review. Am J Epidemiol 2004;
159:319–335.
Morizane M, Yoshida S, Nakago S, Hamana S, Maruo T, Kennedy S. No
association of endometriosis with glutathione S-transferase M1 and T1
null mutations in a Japanese population. J Soc Gynecol Investig 2004;
11:118–121.
Morland SJ, Jiang X, Hitchcock A, Thomas EJ, Campbell IG. Mutation of
galactose-1-phosphate uridyl transferase and its association with
ovarian cancer and endometriosis. Int J Cancer 1998;77:825–827.
Nakago S, Hadﬁeld RM, Zondervan KT, Mardon H, Manek S, Weeks DE,
Barlow D, Kennedy S. Association between endometriosis and N-acetyl
transferase 2 polymorphisms in a UK population. Mol Hum Reprod 2001;
7:1079–1083.
Omori S, Yoshida S, Kennedy SH, Negoro K, Hamana S, Barlow DH,
Maruo T. Polymorphism at codon 72 of the p53 gene is not
associated with endometriosis in a Japanese population. J Soc Gynecol
Investig 2004;11:232–236.
Peng DX, He YL, Qiu LW, Yang F, Lin JM. Susceptibility to endometriosis
in women of Han Nationality in Guangdong Province associated with
Msp I polymorphisms of cytochrome P450 1A1 gene. Di Yi Jun Yi Da
Xue Xue Bao 2002;22:814–816.
Peng DX, He YL, Qiu LW, Yang F, Lin JM. Association between gene
mutation of cytochrome P450 1A1 in exon 7 A4889G locus and
susceptibility to endometriosis. Chin J Med Genet 2003a;20:284–286.
Peng DX, He YL, Qiu LW, Yang F, Lin JM. Association between
glutathione S-transferase M1 gene deletion and genetic susceptibility
to endometriosis. Di Yi Jun Yi Da Xue Xue Bao 2003b;23:458–459, 462.
Pritts EA, Zhao D, Ricke E, Waite L, Taylor RN. PPAR-gamma decreases
endometrial stromal cell transcription and translation of RANTES in
vitro. J Clin Endocrinol Metab 2002;87:1841–1844.
Renner SP, Strick R, Oppelt P, Fasching PA, Engel S, Baumann R,
Beckmann MW, Strissel PL. Evaluation of clinical parameters and
estrogen receptor alpha gene polymorphisms for patients with
endometriosis. Reproduction 2006;131:153–161.
Shan K, Ying W, Jian-Hui Z, Wei G, Na W, Yan L. The function of the SNP
in the MMP1 and MMP3 promoter in susceptibility to endometriosis in
China. Mol Hum Reprod 2005;11:423–427.
Shan K, Lian-Fu Z, Hui D, Wei G, Na W, Xia J, Yan L. Polymorphisms in
the promoter regions of the matrix metalloproteinases-7, -9 and the risk
of endometriosis and adenomyosis in China. Mol Hum Reprod 2006;
12:35–39.
Shan K, Xiao-Wei M, Na W, Xiu-Feng Z, ng-Gui W, Wei G,
Zheng-Mao Z, Yan L. Association of three single nucleotide
polymorphisms of the E-cadherin gene with endometriosis in a
Chinese population. Reproduction 2007;134:373–378.
Stefansson H, Geirsson RT, Guanason GA. A genome-wide search for
endometriosis in Icelandic patients. Am J Hum Genet 1998;63:A310.
Stefansson H, Einarsdottir A, Geirsson RT, Jonsdottir K, Sverrisdottir G,
Gudnadottir VG, Gunnarsdottir S, Manolescu A, Gulcher J,
Stefansson K. Endometriosis is not associated with or linked to the
GALT gene. Fertil Steril 2001;76:1019–1022.
TempferCB,Schneeberger C, HuberJC. Applications of polymorphismsand
pharmacogenomics in obstetrics and gynecology. Pharmacogenomics 2004;
5:57–65.
Tempfer CB, Riener EK, Keck C, Grimm C, Heinze G, Huber JC, Gitsch G,
Heﬂer LA. Polymorphisms associated with thrombophilia and vascular
homeostasis and the timing of menarche and menopause in 728 white
women. Menopause 2005;12:325–330.
Teramoto M, Kitawaki J, Koshiba H, Kitaoka Y, Obayashi H, Hasegawa G,
Nakamura N, Yoshikawa T, Matsushita M, Maruya E et al. Genetic
contribution of tumor necrosis factor (TNF)-alpha gene promoter
(-1031, -863 and -857) and TNF receptor 2 gene polymorphisms in
endometriosis susceptibility. Am J Reprod Immunol 2004;51:352–357.
Treloar SA, O’Connor DT, O’Connor VM, Martin NG. Genetic inﬂuences
on endometriosis in an Australian twin sample. Fertil Steril 1999;
71:701–710.
Treloar SA, Bahlo M, Ewen K. Suggestive linkage for endometriosis found
in genome-wide scan. Am J Hum Genet 2000;67:727–736.
Treloar SA, Zhao ZZ, Armitage T, Duffy DL, Wicks J, O’Connor DT,
Martin NG, Montgomery GW. Association between polymorphisms
in the progesterone receptor gene and endometriosis. Mol Hum
Reprod 2005a;11:641–647.
Treloar SA, Wicks J, Nyholt DR, Montgomery GW, Bahlo M, Smith V et al.
Genomwide linkage study in 1,176 affected sister pair families identiﬁes
Polymorphisms and endometriosis 117a signiﬁcant susceptibility locus for endometriosis on chromosome
10q26. Am J Hum Genet 2005b;77:365–376.
Treloar SA, Zhao ZZ, Le L, Zondervan KT, Martin NG, Kennedy S,
Nyholt DR, Montgomery GW. Variants in EMX2 and PTEN do not
contribute to risk of endometriosis. Mol Hum Reprod 2007;13:
587–594.
Tsuchiya M, Katoh T, Motoyama H, Sasaki H, Tsugane S, Ikenoue T.
Analysis of the AhR, ARNT, and AhRR gene polymorphisms: genetic
contribution to endometriosis susceptibility and severity. Fertil Steril
2005a;84: 454–458.
Tsuchiya M, Nakao H, Katoh T, Sasaki H, Hiroshima M, Tanaka T,
Matsunaga T, Hanaoka T, Tsugane S, Ikenoue T. Association between
endometriosis and genetic polymorphisms of the estradiol-synthesizing
enzyme genes HSD17B1 and CYP19. Hum Reprod 2005b;20:974–978.
van Kaam KJ, Romano A, Dunselman GA, Groothuis PG. Transforming
growth factor beta1 gene polymorphism 509C/T in deep inﬁltrating
endometriosis. Reprod Sci 2007a;14:367–373.
van Kaam KJ, Romano A, Schouten JP, Dunselman GA, Groothuis PG.
Progesterone receptor polymorphism þ331G/A is associated with a
decreased risk of deep inﬁltrating endometriosis. Hum Reprod 2007b;
22:129–135.
VietriMT,MolinariAM,IannellaI,CiofﬁM,BontempoP,ArdovinoM,ScaffaC,
Colacurci N, CobellisL.Arg72Prop53 polymorphisminItalianwomen: no
association with endometriosis. Fertil Steril 2007;88:1468–1469.
Vigano P, Infantino M, Lattuada D, Lauletta R, Ponti E, Somigliana E,
Vignali M, DiBlasio AM. Intercellular adhesion molecule-1 (ICAM-1)
gene polymorphisms in endometriosis. Mol Hum Reprod 2003;9:47–52.
Vigano P, Lattuada D, Somigliana E, Abbiati A, Candiani M, Di Blasio AM.
Variants of the CTLA4 gene that segregate with autoimmune diseases are
not associated with endometriosis. Mol Hum Reprod 2005;11: 745–749.
Vigano P, Somigliana E, Vignali M, Busacca M, Blasio AM. Genetics of
endometriosis: current status and prospects. Front Biosci 2007;12:
3247–3255.
Wang X, Lin Q, Guo S. Study on polymorphism of human leukocyte
antigen I in patients with endometriosis. Zhonghua Fu Chan Ke Za Zhi
2001;36:150–152.
Wang X, Liu C, Lin Q, Fang X, Lin L, Mei Q. Study on polymorphism of
human leukocyte antigen-DRB1 allele in patients with endometriosis.
Zhonghua Fu Chan Ke Za Zhi 2002;37:346–348.
Wang Z, Yoshida S, Negoro K, Kennedy S, Barlow D, Maruo T.
Polymorphisms in the estrogen receptor beta gene but not estrogen
receptor alpha gene affect the risk of developing endometriosis in a
Japanese population. Fertil Steril 2004;81:1650–1656.
Watanabe T, Imoto I, Kosugi Y, Fukuda Y, Mimura J, Fujii Y, Isaka K,
Takayama M, Sato A, Inazawa J. Human arylhydrocarbon receptor
repressor (AHRR) gene: genomic structure and analysis of
polymorphism in endometriosis. J Hum Genet 2001;46:342–346.
Wen J, Deng L, Zhang XM. Research on relationship between gene
polymorphisms of interleukin-1 family and endometriosis. Zhejiang Da
Xue Xue Bao Yi Xue Ban 2006;35:653–657.
Wenzl R, Kiesel L, Huber JC, Wieser F. Endometriosis: a genetic disease.
Drugs Today (Barc) 2003;39:961–972.
Whang DH, Kim SH, Choi YM, Park MH, Noh JH, Kim YB. No association
between HLA-DRB1 alleles and susceptibility to advanced stage
endometriosis in a Korean population. Hum Reprod 2006;21:
129–133.
Wieser F, Fabjani G, Tempfer C, Schneeberger C, Zeillinger R, Huber JC,
Wenzl R. Tumor necrosis factor-alpha promotor polymorphisms and
endometriosis. J Soc Gynecol Investig 2002a;9:313–318.
Wieser F, Schneeberger C, Tong D, Tempfer C, Huber JC, Wenzl R.
PROGINS receptor gene polymorphism is associated with
endometriosis. Fertil Steril 2002b;77:309–312.
Wieser F, Wenzl R, Tempfer C, Worda C, Huber J, Schneeberger C.
Catechol-O-methyltransferase polymorphism and endometriosis.
J Assist Reprod Genet 2002c;19:343–348.
Wieser F, Fabjani G, Tempfer C, Schneeberger C, Sator M, Huber J,
Wenzl R. Analysis of an interleukin-6 gene promoter polymorphism in
women with endometriosis by pyrosequencing. J Soc Gynecol Investig
2003a;10:32–36.
Wieser F, Heﬂer L, Tempfer C, Vlach U, Schneeberger C, Huber J,
Wenzl R. Polymorphism of the interleukin-1beta gene and
endometriosis. J Soc Gynecol Investig 2003b;10:172–175.
Wu MY, Chao KH, Yang JH, Lee TH, Yang YS, Ho HN. Nitric oxide
synthesis is increased in the endometrial tissue of women with
endometriosis. Hum Reprod 2003;18:2668–2671.
Yamashita M, Yoshida S, Kennedy S, Ohara N, Motoyama S, Maruo T.
Association study of endometriosis and intercellular adhesion
molecule-1 (ICAM-1) gene polymorphisms in a Japanese population.
J Soc Gynecol Investig 2005;12:267–271.
Zervou S, Karteris E, Goumenou AG, Vatish M, Koumantakis EE,
Hillhouse EW. The Glu298–.Asp polymorphism of the endothelial
nitric oxide synthase gene is associated with endometriosis. Fertil Steril
2003;80:1524–1525.
Zhao ZZ, Nyholt DR, Le L, Martin NG, James MR, Treloar SA,
Montgomery GW. KRAS variation and risk of endometriosis. Mol
Hum Reprod 2006;12:671–676.
Zhao ZZ, Nyholt DR, Le L, Thomas S, Engwerda C, Randall L, Treloar SA,
Montgomery GW. Genetic variation in tumour necrosis factor and
lymphotoxin is not associated with endometriosis in an Australian
sample. Hum Reprod 2007;22:2389–2397.
Zondervan KT, Cardon LR, Kennedy SH. What makes a good
case-control study? Design issues for complex traits such as
endometriosis. Hum Reprod 2002;17:1415–1423.
Zondervan KT, Treloar SA, Lin J, Weeks DE, Nyholt DR, Mangion J et al.
Signiﬁcant evidence of one or more susceptibility loci for endometriosis
with near-Mendelian inheritance on chromosome 7p13-15. Hum Reprod
2007;22:717–728.
Submitted on March 11, 2008; resubmitted on July 1, 2008; accepted on July 16,
2008
118 Tempfer et al.